Dublin, May 12, 2022 (GLOBE NEWSWIRE) -- The "Global Catheter Market, Size, Share, Forecast 2022-2027, Industry Trends, Growth, Outlook, Impact of COVID-19, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.
This report provides an all-encompassing analysis on the Global Catheter Market. The market will be US$ 68.95 Billion by 2027.
The plurality of chronic disorders, such as cardiovascular diseases, cancer, urinary tract infections, and neurological diseases, is increasing across the globe, leading to the rising demand for medical devices such as catheters. Catheters are used to deliver medicines and gases into the bodies and are also used in acute care facilities to monitor and manage drainage of bodily fluids, such as urine, during surgery and post-operative recovery. It is manufactured using medical-grade materials, such as silicone rubbers, plastic, latex, polyvinyl chloride (PVC), and nylon. Global Catheter Industry will grow with a CAGR of 7.3% during 2021-2027
Across the globe, the rising prevalence of urological disorders is one of the key factors driving the market's growth. Likewise, the increasing geriatric population, which is more susceptible to such diseases and the growing preference for (MI) minimally invasive surgeries provide a thrust to the market growth. These catheters are also widely utilized in hospitals, specialty clinics, and ambulatory surgical for electrophysiological procedures that use catheters to insert wire electrodes to measure electrical activity in the blood vessels entering the heart. Further, various technological advancements, such as the utilization of robot-assisted surgical interventions, are acting as other growth-inducing factors. COVID-19 Impact on Catheter Industry
In line with this, the COVID-19 scenario profoundly impacts the global catheter market. As the number of cases is still on the rise, the demand for catheters also increases since catheters are used in some critically ill patients suffering from COVID-19.
As governments and healthcare institutions are found improving efficient medical treatment to treat COVID-19 patients, the usage of catheters will behold an upsurge in hospitals and emergency clinics. Patients with confirmed or suspected or diagnosis of COVID-19 are being treated with catheters; therefore, the demand for these devices may remain huge throughout the pandemic. Thus, this is to impact the demand for catheters positively. Cardiovascular Catheters Segment is anticipated to maintain its Dominance throughout the Projection Period
Based on product type, the catheters market is categorized into Cardiovascular, Neurovascular, Urology, Intravenous, and Specialty. The cardiovascular catheters segment has the highest contribution to the market and is anticipated to maintain its dominance throughout the projection period. Owing to the increase in the need for interventional cardiac procedures and the rise in cardiovascular disorders' prevalence.
This is associated with the increasing adoption of cardiac catheter products like angiography catheters, IVUS/OCT catheters, guiding catheters, electrophysiology catheters, and balloon catheters. Nevertheless, a urinary catheter is found to be necessary for a person facing difficulty passing urine naturally. The Urology segment has shown substantial growth due to urinary catheter products being used for patients who suffer from urological disorders, urinary incontinence, and urinary retention. Geographically, North America is expected to influence the market during the Forecast Period. North America, the United States, is the most significant catheter industry. This is attributed to many target procedures performed in the country, investments by hospitals to upgrade & expand operating capabilities, and the presence of a well-established healthcare system. For instance, in 2020, according to the American Cancer Society, the new cases of bladder cancer in Americans were 81,400, and about 17,980 deaths occurred in the United States. Similarly, the market in the APAC is to witness significant growth in the coming years due to favorable regulatory guidelines and government support, lower manufacturing costs, the growing presence of market players in emerging economies, and constant growth in healthcare expenditure. According to this report Worldwide Catheter Market Size was US$ 45.30 Billion in 2021. Key Companies
Edwards Life sciences, Teleflex, Fresenius Medical Care AG KGaA, BdCompany, Boston Scientific, Abbott Laboratories, Terumo Corporation, Johnson & Johnson, Medtronic Companies are constantly launching new products and increasing their reach by geographically expanding to gain a more substantial market share. For instance, in 2020, Boston received approval for the Ranger Paclitaxel-coated PTA Balloon Catheter.
Key Topics Covered: 1. Introduction 2. Research Methodology 3. Executive Summary 4. Market Dynamics 4.1 Growth Drivers 4.2 Challenges 5. Global Catheter Market 6. Market Share - Global Catheter Market 6.1 By Product Type 6.2 By End Users 6.3 By Regions 7. Product Type - Global Catheter Market 7.1 Cardivascular 7.2 Neurovasular 7.3 Urology 7.4 Intravenous 7.5 Specialty 8. End Users - Global Catheter Market 8.1 Hospital & Clinics 8.2 Specialty Centers 8.3 Ambulatory Surgical Centers 8.4 Others 9. Regions - Global Catheter Market 9.1 North America 9.2 Europe 9.3 Asia Pacific 9.4 Row 10. Porters Five Forces 10.1 Overview 10.2 Bargaining Power of Buyers 10.3 Bargaining Power of Suppliers 10.4 Degree of Competition 10.5 Threat of New Entrants 10.6 Threat of Substitutes 11. Company- Global Catheter Market 11.1 Edwards Lifesciences 11.1.1 Overview 11.1.2 Recent Initiative 11.1.3 Revenue 11.2 Teleflex 11.2.1 Overview 11.2.2 Recent Initiative 11.2.3 Revenue 11.3 Fresenius Medical Care AG KGaA 11.3.1 Overview 11.3.2 Recent Initiative 11.3.3 Revenue 11.4 BdCompany 11.4.1 Overview 11.4.2 Recent Initiative 11.4.3 Revenue 11.5 Boston Scientific 11.5.1 Overview 11.5.2 Recent Initiative 11.5.3 Revenue 11.6 Abbott Laboratories 11.6.1 Overview 11.6.2 Recent Initiative 11.6.3 Revenue 11.7 Terumo Corporation 11.7.1 Overview 11.7.2 Recent Initiative 11.7.3 Revenue 11.8 Johnson & Johnson 11.8.1 Overview 11.8.2 Recent Initiative 11.8.3 Revenue 11.9 Medtronic 11.9.1 Overview 11.9.2 Recent Initiative 11.9.3 Revenue
For more information about this report visit https://www.researchandmarkets.com/r/tcfpp9
(Bloomberg) -- Bill Gates has a short position against Tesla Inc. that would now need between $1.5 billion and $2 billion to close out, Elon Musk said Friday in a series of tweets.Most Read from BloombergElon Musk Says Bill Gates Has ‘Multi-Billion Dollar’ Tesla Short PositionElizabeth Holmes Urges Judge to Overturn Verdict and Acquit HerWalmart, Gap and Others Amass $45 Billion in Extra Stuff to SellRussian Wins in Eastern Ukraine Spark Debate Over Course of WarUkraine Latest: EU Leaders Talk t
Amazon's stock split will take place on June 3, but don't expect to wake up to riches overnight.
Stop investing in mediocre businesses. Buy the best, instead.
When looking for the best artificial intelligence stocks to buy, identify companies using AI technology to improve products or gain a strategic edge, such as Google, Microsoft and Nvidia.
Real estate mogul Barbara Corcoran didn't mince words when asked about Tesla (TSLA) CEO Elon Musk's recent behavior.
Whether you're looking for household goods at discounted prices or need to buy your grocery items in bulk, Costco is the go-to retailer for millions of shoppers across the U.S. But despite its ability to attract a loyal following, Costco has made a number of changes recently that haven't thrilled customers. In April, the warehouse retailer got rid of its special COVID hours for seniors, and just this month, Costco ended its mortgage program for members. Now, the retailer has a new warning for sh
The Dow Jones rallied amid encouraging inflation data. Tesla stock jumped even as CEO Elon Musk issued a warning. Apple stock surged.
The stock market pulled back from the brink of a bear market as rate-hike expectations eased, at least for now. Here's what it will take to signal a bottom.
Markets are shaky. Your income stream doesn’t have to be.
The stock market selloff has made many stocks look cheap—but smart investors need to be selective. Here are six high-quality companies that trade at reasonable valuations.
The stock market ended its multiweek losing streak, and like a sports team that finally got a win, it’s worth celebrating. It just doesn’t mean the team—or this stock market—is any good. “Stocks finally enjoyed a strong bounce this week,” writes Canaccord Genuity analyst Martin Roberge.
Concerns about high inflation and rising interest rates have hit retail stocks particularly hard in recent weeks. Target (NYSE: TGT) disappointed investors when higher-than-expected costs hurt profitability in the first quarter. Target reported its 20th straight quarter of sales growth.
The top-ranked companies on dividend payout ratios outperformed those stocks with less robust buyback activity—10.9% versus 9.3% on an annual basis over the 20-year period that concluded at the end of 2019.
The highest paid CEOs in America in 2021, according to Fortune's new analysis of executive pay.
Qualcomm CEO Cristiano Amon weighs in on the outlook for the semiconductor industry and his company's future.
Investors finally got the week they had hoped to see, producing a sizable rebound from last week's stock market lows. There's still plenty of uncertainty in the economy, but investors are starting to think that the Federal Reserve might not be as aggressive as feared in fighting inflation. The Dow Jones Industrial Average (DJINDICES: ^DJI), S&P 500 (SNPINDEX: ^GSPC), and Nasdaq Composite (NASDAQINDEX: ^IXIC) were all up substantially on the week, including big gains on Friday.
In this article, we will discuss some of the notable stocks analysts are upgrading today. To take a look at some more stocks that are being upgraded, go to Analysts Are Upgrading These 5 Stocks on Friday. The US market closed in the green for the first time in the last seven weeks as positive […]
Wood's flagship Ark Innovation ETF has fallen 52% this year as technology companies have tumbled.
Only time will tell how much record US prices at the pump will dent driving demand this summer, but don't expect a significant increase in gasoline supply from American refineries.
Despite all the attention that renewable energy companies get, having operations in the renewable energy space alone does not make a stock a buy. In fact, several renewable energy companies are struggling just to stay profitable. Let's discuss two renewable energy stocks that look attractive right now, and one that's best avoided.